Sigrid Therapeutics Announces SiPore15TM Selected for Oral Presentation at Upcoming 28th European Diabetics Congress in Edinburgh
Novel silica particle-based therapy significantly reduces blood sugar and other metabolic risk factors
Novel silica particle-based therapy significantly reduces blood sugar and other metabolic risk factors